朗姿股份有限公司第五届董事会第三十七次会议决议公告

Group 1 - The company held its 37th meeting of the fifth board of directors on January 16, 2026, to discuss and approve a proposal regarding joint investment with related parties [2][4] - The proposal aims to accelerate the national layout strategy of the company's medical beauty business and establish a long-term incentive and restraint mechanism for key employees [3][8] - The company has been utilizing employee stock ownership platforms to jointly invest in new medical beauty institutions since July 2017, with the full subsidiary, Langzi Medical Management Group Co., Ltd., acting as the general partner [3][8] Group 2 - The board approved the proposal with a unanimous vote, with one related director abstaining from the vote [4][9] - The independent directors held a special meeting and agreed that the pricing and terms of the related transactions are fair and do not harm the interests of the company or its minority shareholders [29][30] - The expected investment amounts for key personnel involved in the employee stock ownership platforms were detailed, with specific figures provided for each individual [10][12][14][15]